Of the various drugs currently suggested for the treatment of malignant hyperpyrexia, dantrolene sodium was the most effective in reversing and inhibiting drug induced contractures in vitro, both in normal muscle and in muscle from patients who are susceptible to malignant hyperpyrexia. It is suggested that dantrolene sodium is the drug of choice for 10'wering the raised myoplasmic calcium concentrations in malignant hyperpyrexia. Recently, the skeletal muscle relaxant dantrolene sodium (Ellis and Bryant 1972) , has been used successfully in vivo to treat malignant hyperpyrexia in swine (Harrison 1975) . This
INTRODUCTION
Although the clinical features of malignant hyperpyrexia are known to be the consequences of an excess of calcium ions in the myoplasm of the affected individual (Kalow et al. 1970, Moulds and Denborough 1974a) , a specific treatment for this syndrome has yet to be established. One drug that has been tried is procaine, because this inhibits the halothaneinduced contracture of muscle from patients who are susceptible to malignant hyperpyrexia (Moulds and Denborough 1972) . However, large doses of procaine are required to produce the desired effect in vitro, and with the use of equivalent doses in vivo, there is the danger of producing cardiovascular collapse. Other drugs that have been tried in the treatment of malignant hyperpyrexia include pro cain amide (Noble, McKee and Gates 1973) , hydrocortisone and dexamethasone (Ellis et al. 1974) . Unfortunately, the mortality from malignant hyperpyrexia remains high, and at present there is doubt about which drug is the best to use in the clinical emergency of an episode of malignant hyperpyrexia, has prompted us to study the effects of dantrolene sodium on pharmacologically induced contracture in human muscle from normal subjects and from patients who are susceptible to malignant hyperpyrexia, and to compare these with the results of similar experiments using procaine, procainamide, hydrocortisone and dexamethasone. The aim of the study has been to determine which is the most effective drug that is currently available for the treatment of malignant hyperpyrexia in man.
MATERIAL AND METHODS
Normal muscle was obtained with consent from the rectus abdominis muscle of patients undergoing elective abdominal surgery. The muscle from patients susceptible to malignant hyperpyrexia was obtained under local anaesthesia from the vastus lateralis muscle. The methods of preparing fibres and measuring isometric tension were as described previously (Moulds and Denborough 1974a) . Halothane was administered by flowing carbogen through a calibrated Dragewick vaporiser.
Caffeine contracture and caffeine-potentiated halothane contracture were used as models for malignant hyperpyrexia in normal muscle. 8 mM caffeine induces contracture in normal human skeletal muscle by elevating the calcium concentration in the myoplasm. Halothane alone does not usually cause contracture in normal human skeletal muscle, but invariably does so in the presence of 2 mM caffeine. The effects of dantrolene sodium, procaine, procainamide, hydrocortisone and dexamethasone on both inhibiting and relaxing caffeine and caffeine-K. L. AUSTIN AND 1\1. A. DEN BOROUGH potentiated halothane contractures in normal human muscle in vitro were compared. For the inhibitory studies, the drugs were added to the muscle preparation 6 minutes before contracture was pharmacologically induced. An example of the inhibitory effect of dantrolene sodium on 8 mM caffeine contracture in normal human muscle is shown in Figure 1 . The degree of relaxation induced by the drugs was assessed by t DANTROLENE FIGURE I.-Inhibition of an 8 mM caffeine contracture in normal human muscle by dantrolene sodium. The dantrolene sodium (6 [1.M) was added 6 minutes before the caffeine. The change in tension (g) is shown on the vertical axis, and the duration of the contracture in minutes is shown on the horizontal axis. The key in the upper left-hand corner illustrates a change in tension of 1 g and a duration of 2 minutes. In the upper experiment, 8 mM caffeine has induced a contracture of about 5 g in the absence of dantrolene. In the lower experiment, the presence of 6 [1.:\1 dantrolene sodium has inhibited the 8 m11 caffeine contracture to less than 1 g, and the time to peak contracture has been prolonged.
adding the drugs after the pharmacologically induced contractures had reached a steady-state. Examples of the muscle relaxation induced by procaine and dantrolene sodium on 8 mM caffeine and 2 mM caffeine potentiated 3 % halothane contractures is shown in Figure 2 . Two concentrations of each of the drugs were used. The lower concentration was selected to fall within the usual therapeutic range. The higher concentration was chosen to provide a means of assessing the effects of large doses of the drugs which might be used in an emergency. The concentrations selected were: procaine hydrochloride 0·5 mM and 5 mM, procainamide hydrochloride (Pronestyl) 0·5 mM and 5 mM, hydrocortisone 55 fLM and 552 fLM, dexamethasone 7·8 fLM and 77·5 fLM, and dantrolene sodium 6 fLM and 30 fLM.
In normal muscle effects of these drugs were compared on 8 mM caffeine and 2 mM caffeine potentiated 3 % halothane contractures.
In muscle from patients who were susceptible to malignant hyperpyrexia, the effects of the drugs were assessed on the 3 % halothane, 2 mM caffeine, 1 mM suxamethonium and 80 mM KCl contractures which are diagnostic of this syndrome (Moulds and Denborough 1974a) .
CONTl<Ol
relaxation induced by procaine (0'5 mM) and dantrolene sodium (6 [1.M) on 8 mM caffeine and 2 mM caffeine potentiated 3% halothane contractures. The procaine and dantrolene sodium were added to the muscle bath when the contractures had reached steady-state levels. The arrows indicate the points at which drugs were added to the normal muscle preparations. The change in tension (g) is shown on the vertical axis, and the duration of the contracture in minutes is shown on the horizontal axis.
Caffeine was freshly prepared before each experiment as a stock concentration of 100 m:'ll in the standard muscle buffer. Fresh solutions of dantrolene sodium were prepared as a stock solution of 148· 7 fLM in 10 mM NaOH. Procaine and procainamide were both prepared as stock solutions of 250 m:vI in the standard muscle buffer at pH 7 ·3. Pronestyl was supplied as a 10% aqueous solution. Hydrocortisone was supplied as Efcortelan Soluble and dexamethasone as Decasone.
The computation and analysis of the data was carried out on a UNIV AC 1108 Computer using a P-ST AT programming system.
Dantrolene sodium was a gift from Norwich Pharmacal Company, U.S.A. Procaine and procainamide were supplied by the Sigma 
Drug effects at clinical concentrations on normal human muscle (a) Drug induced relaxation
Dantrolene sodium and procaine induced immediate and sustained relaxation of both caffeine contractures and caffeine potentiated halothane contractures (Table 1 ). The degree of relaxation induced by dantrolene sodium was significantly greater than that induced by procaine for both types of contracture (p<O'OOOl, p<0·0005). None of the other drugs studied had a significant effect on relaxation.
(b) Drug inhibition of contractures
Dantrolene sodium inhibited 8 mM caffeine contractures by about 75% (Table 2) , and also prolonged the time to peak contracture ( Figure 1) . None of the other drugs tested significantly inhibited caffeine contractures.
Dantrolene sodium also inhibited caffeine potentiated halothane contractures by almost 60 %, whereas none of the other drugs had a (Table 3 ). The differences in the control values in different groups are explained by differences in sensitivity to caffeine and halothane in different patients.
with dantrolene sodium was also significantly greater than that seen after any of the other drugs.
Drug effects at high concentrations on normal human muscle (a) Drug induced relaxation
Dantrolene sodium immediately and completely reversed caffeine and caffeine potentiated halothane contractures and the relaxation was sustained (Figure 2 ). Procaine also caused relaxation but the extent of reversal was significantly less than with dantrolene sodium ( Table 4 ). The degree of relaxation achieved
(b) Drug inhibition of contractures
Both dantrolene sodium and procaine prolonged the onset of contracture and the size of 8 mM caffeine contractures by about 80%. None of the other four drugs tested had any significant effect on the tension developed by the fibres (Table 5) .
Dantrolene sodium was the most efficient drug in inhibiting caffeine potentiated halothane contractures (Table 6) , although procaine and hydrocortisone also had some effect. Anaesthesia and Intensive Care, Vol. V, No. 3, August, 1977 
Drug effects on human malignant hyperpyrexia muscle
Skeletal muscle from an individual who is susceptible to malignant hyperpyrexia gives an abnormally large contracture when exposed to halothane, caffeine, suxamethonium or KCI in vitro (Moulds and Denborough 1974b) . 2 m:\l caffeine, 1 m:\l succinylcholine and 80 m:\l KCl in muscles from two patients who were susceptible to malignant hyperpyrexia (Figure 3 ). Dantrolene sodium in low dosage was more efficient than either high dose hydrocortisone inhibiting halothane induced contracture in malignant hyperpyrexia muscle (Figure 4 ). Dantrolene sodium (6 [1-:\1) caused total, immediate and sustained relaxation of halothane induced contracture in malignant hyperpyrexia muscle. A lower dose of dantrolene sodium (3 [1-:\1) also reversed a 3% halothane contracture and 2 mM caffeine contracture in this muscle ( Figure 5 ). In contrast, dexamethasone (7' 75 [1-1\I) and hydrocortisone (552 [1-M) failed to alter the rate of relaxation of a similar halothane induced contracture.
DrsccssIOX
The results of the present investigation suggest that dantrolene sodium is the most effective drug to use to reverse the elevated myoplasmic calcium levels, which form the biochemical basis of malignant hyperpyrexia.
Dantrolene sodium in concentrations which could be readily achieved clinically, was far more effective in reversing and inhibiting caffeine and caffeine potentiated halothane contractures in normal muscle than any of the other drugs which were studied. Dantrolene sodium was also the most efficient drug in reversing halothane-induced contractures in muscle from patients who were susceptible to malignant hyperpyrexia. It also inhibited completely the succinylcholine, 2 m:\I caffeine and potassium chloride contractures which together with halothane-induced contractures form the basis of an in vitro muscle test which has been used to define susceptibility to malignant hyperpyrexia. Anaesthesia and Inltnsive Care, Vol. l", Xo . .3, August, 1977 The results obtained in the present study with human muscle support the favourable results obtained with dantrolene sodium by Harrison (1975) in his in vivo experiments on the treatment of malignant hyperpyrexia in susceptible pigs. It is encouraging that although Harrison has suggested that dantrolene sodium blood concentrations as high as 237-297 fLM are necessary to prevent the onset of porcine malignant hyperpyrexia, we have found that lower levels (3-6 fLM) completely inhibited and reversed the abnormal drug induced contractures diagnostic of malignant hyperpyrexia in human muscle in vitro.
The high doses of dantrolene sodium given to pigs did not induce any serious side-effects (Harrison 1975) , and similarly, high blood concentrations had no effect on dogs (Ellis et al. 1975) . The blood concentration of 6 fLM suggested from the results of the present investigation appears to be safe in man. The main side-effects after oral treatment with dantrolene sodium over a period of four weeks with steady-state blood levels of about 6 fLM are general weakness, drowsiness, fatigue, dizziness, drunk feeling, headache and insomnia Bergman 1971) .
The fulminant nature of malignant hyperpyrexia means that an intravenous preparation of dantrolene sodium would be needed for the treatment of this syndrome. This has yet to be approved in the United Kingdom or in America, and dantrolene sodium is not yet available at all in Australia. The results of the present investigation suggest that there is an urgent need for the development of an intravenous preparation of dantrolene sodium for use in man.
